Organon & Co | OGN - Umsatzerlöse

Aktienkurs
6.13
Täglich Wechseln
0.08 1.32%
Monatlich
-6.13%
Jährlich
-47.04%
Q2 Prognose
6.17




Der Umsatz Veränderung Datum
Bristol-Myers Squibb USD 12.5B 300M 2025-12
Celltrion KRW 1.33T 0 2026-03
Cspc Pharmaceutical CNY 6.11B 502.75M 2025-12
Deva Holding AS TRY 2.32B 418.58M 2023-09
Dianthus Therapeutics USD 284K 112K 2025-12
Divis Laboratories Ltd INR 26.04B 1.11B 2025-12
Gilead Sciences USD 7.93B 130M 2025-12
Glaxosmithkline GBP 11.46B 59.16M 2025-12
Kangmei Pharma CNY 1.37B 101.16M 2025-09
Knight Therapeutics CAD 133.11M 11.56M 2025-12
Laboratorios Farma EUR 448.66M 67.82M 2023-12
Medical Developments International AUD 21.57M 12.04M 2025-12
Merck USD 16.4B 880M 2025-12
Neuren Pharmaceuticals AUD 42.24M 28.1M 2025-12
Novartis USD 13.86B 498M 2025-12
Organigram Holdings CAD 63.54M 16.52M 2025-12
Organon & Co USD 1.51B 90M 2025-12
Pharma Mar EUR 90.2M 54.5M 2025-12
Qiagen NV USD 457.38M 6.06M 2025-12
Sartorius EUR 927.6M 84.4M 2025-12
Sino Biopharmaceutical CNY 14.26B 3.31B 2025-12
Tilray USD 217.51M 74.75M 2025-12
Zealand Pharma A/S 68.91M 19.35M 2025-12